These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 18218647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A, Koncan R, Vitali LA, Cornaglia G.
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [Abstract] [Full Text] [Related]

  • 3. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A, Koncan R, Bahar G, Cornaglia G.
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [Abstract] [Full Text] [Related]

  • 4. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J, Pérez-Trallero E, Gómez-Garcés JL, Alós JI, Spanish Group for the Study of Infection in the Primary Health Care Setting.
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe.
    Bozdogan B, Appelbaum PC, Kelly LM, Hoellman DB, Tambic-Andrasevic A, Drukalska L, Hryniewicz W, Hupkova H, Jacobs MR, Kolman J, Konkoly-Thege M, Miciuleviciene J, Pana M, Setchanova L, Trupl J, Urbaskova P.
    Clin Microbiol Infect; 2003 Jul; 9(7):741-5. PubMed ID: 12925122
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study].
    Gür D, Mülazimoğlu L, Unal S, e-BASKETT-II Calişma Grubu.
    Mikrobiyol Bul; 2007 Jan; 41(1):1-9. PubMed ID: 17427547
    [Abstract] [Full Text] [Related]

  • 10. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
    Morosini MI, Cantón R, Loza E, del Campo R, Almaraz F, Baquero F.
    J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
    [Abstract] [Full Text] [Related]

  • 11. Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators.
    Shackcloth J, Williams L, Farrell DJ.
    J Infect; 2004 Apr; 48(3):229-35. PubMed ID: 15001301
    [Abstract] [Full Text] [Related]

  • 12. In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
    Banche G, Roana J, Allizond V, Andreotti S, Malabaila A, Li Vigni N, Mandras N, Scalas D, Tullio V, Carlone NA, Savoia D, Gaido E, Barbui A, Cuffini AM.
    Lett Appl Microbiol; 2008 Oct; 47(4):309-14. PubMed ID: 19241525
    [Abstract] [Full Text] [Related]

  • 13. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
    Kim NJ, Park SJ, Choi SH, Lee MS, Choo EJ, Kwak YG, Woo JH, Ryu J, Jeong JY, Kim YS.
    Microb Drug Resist; 2005 Oct; 11(3):260-5. PubMed ID: 16201929
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Telithromycin activity is reduced by efflux in Streptococcus pyogenes.
    Cantón R, Mazzariol A, Morosini MI, Baquero F, Cornaglia G.
    J Antimicrob Chemother; 2005 Apr; 55(4):489-95. PubMed ID: 15705635
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K, Sadowy E, Izdebski R, Hryniewicz W.
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.